AMAM   $10.56  -11.37% Market Closed

Ambrx Biopharma Inc
Total Cash 225.26M
totalCashPerShare 3.567
EBITDA -61.75M
Total Debt 10.52M
quickRatio 12.46
currentRatio 12.799
Total Revenue 4.09M
debtToEquity 4.341
Revenue/Share 0.015
ROA -0.18621
ROE -0.37227002
grossProfits
freeCashflow -34.50M
operatingCashflow -57.70M
earningsGrowth
revenueGrowth -0.967
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -483.5094
profitMargins 0.0
enterpriseValue 1.55B
forwardPE -17.948719
floatShares 21.92M
sharesOutstanding 63.29M
sharesShort 1.16M
sharesShortPriorMonth 1.74M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.03%
Short Ratio help_outline 1.21%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 3.847
Price To Book help_outline 7.28
earningsQuarterlyGrowth
netIncomeToCommon -67.06M
trailingEps 0.42%
forwardEps -1.56%
enterpriseToEbitda -25.16
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.4 4Q 2023
institutionsCount 94
lastUpdated April 16, 2024, 9:53 p.m.